Company patents
NEVRO CORP.
NEVRO CORP. exhibits a highly concentrated patent strategy, with an overwhelming 96.6% of its portfolio dedicated to Electrotherapy / Radiation Therapy, a category that saw a 4.3% YoY growth in 2025 but a significant -37.5% decline so far in 2026. Despite this core focus, the company shows a nascent interest in Medical Diagnostics & Surgery, which accounts for 7.9% of its portfolio and maintained its patent output in 2026, suggesting a potential diversification beyond its primary electrotherapy applications.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
89 US filings (since 2023) · 6 categories · 6 themes
Therapeutic application of electrical signals to nerves or tissues to modulate their activity, often using implantable devices, electrodes, and sophisticated programming for various conditions.
Systems that provide therapeutic stimulation or field therapy through wearable devices, often incorporating physiological sensing and closed-loop feedback for personalized and adaptive treatment.
Use of alternating electric or magnetic fields at specific frequencies and intensities to achieve therapeutic effects, such as inhibiting cell proliferation (e.g., cancer) or modulating cytokine production.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Integrated systems and specialized instruments for performing delicate surgical procedures on the eye, often involving the delivery, manipulation, or monitoring of ophthalmic implants.
Implantable devices used for the fixation, fusion, or replacement of bone structures, particularly in the spine and extremities.
Patents
Showing 1-2 of 2
Orthopedic & Spinal Implants